Correlation Between Immunome and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Immunome and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Cue Biopharma, you can compare the effects of market volatilities on Immunome and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Cue Biopharma.
Diversification Opportunities for Immunome and Cue Biopharma
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Immunome and Cue is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Immunome i.e., Immunome and Cue Biopharma go up and down completely randomly.
Pair Corralation between Immunome and Cue Biopharma
Given the investment horizon of 90 days Immunome is expected to generate 0.84 times more return on investment than Cue Biopharma. However, Immunome is 1.19 times less risky than Cue Biopharma. It trades about 0.15 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.13 per unit of risk. If you would invest 1,147 in Immunome on September 1, 2024 and sell it today you would earn a total of 208.00 from holding Immunome or generate 18.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunome vs. Cue Biopharma
Performance |
| Timeline |
| Immunome |
| Cue Biopharma |
Immunome and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunome and Cue Biopharma
The main advantage of trading using opposite Immunome and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
| Cue Biopharma vs. Tff Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics | Cue Biopharma vs. Inhibrx | Cue Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |